Status:
COMPLETED
Comparative Results After DSAEK, UT-DSAEK and DMEK for Fuchs Endothelial Corneal Dystophy
Lead Sponsor:
Centre Hospitalier Régional Metz-Thionville
Conditions:
Corneal Dystrophy
Eligibility:
All Genders
18+ years
Brief Summary
Purpose of the research is to describe and compare the evolution of BSCVA after DMEK, DSAEK and UT-DSAEK for Fuchs Endothelial Corneal Dystrophy (FECD) and Moderate Pseudophakic Bullous Keratopathy (P...
Detailed Description
The purpose of the research is to Describe and compare the evolution of BSCVA after DMEK, DSAEK and UT-DSAEK for Fuchs Endothelial Corneal Dystrophy (FECD) and Moderate Pseudophakic Bullous Keratopath...
Eligibility Criteria
Inclusion
- Patients requiring posterior lamellar transplantation for FECD or moderate PBK, with preoperative BSCVA of less than 0.3 logmar,
Exclusion
- Patients with pathologies that may seriously affect VA postoperatively
Key Trial Info
Start Date :
August 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2019
Estimated Enrollment :
218 Patients enrolled
Trial Details
Trial ID
NCT04424550
Start Date
August 1 2017
End Date
August 1 2019
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chr Metz Thionville
Metz, France, 57085